| DFS | OS | ||||
---|---|---|---|---|---|---|
P | HR | 95% CI | P | HR | 95% CI | |
Gender | ||||||
 Male | 1 |  |  | 1 |  |  |
 Female | 0.02* | 0.48 | 0.26–0.86 | 0.03* | 0.45 | 0.22–0.92 |
Tumor deposits | ||||||
 Without | 1 |  |  | 1 |  |  |
 With | < 0.01* | 3.00 | 1.49–6.02 | < 0.01* | 5.36 | 2.62–10.98 |
CEA level | ||||||
 Normal | 1 |  |  |  |  |  |
 Elevated | 0.05* | 1.70 | 1.00–2.89 |  |  |  |
CA19-9 level | Â | Â | Â | Â | Â | Â |
 Normal |  |  |  | 1 |  |  |
 Elevated |  |  |  | < 0.01* | 2.54 | 1.33–4.85 |
BMI (kg/m2) |  |  |  | 0.05* | 0.92 | 0.84–1.00 |
Combined N stages | ||||||
 N0 | 1 |  |  |  |  |  |
 N1 + N2 | 0.02* | 2.01 | 1.15–3.51 |  |  |  |
LFR | ||||||
 Low | 1 |  |  | 1 |  |  |
 High | < 0.01* | 0.32 | 0.16–0.61 | < 0.01* | 0.23 | 0.09–0.55 |